Yahoo Web Search

  1. Merck & Co., Inc. MRK announced that its blockbuster drug, Keytruda, in combination with Lenvima, received accelerated approval from the FDA as a treatment for advanced endometrial carcinoma ...

  2. Amgen announced that a three-drug combination regimen of its multiple myeloma (MM) drug, Kyprolis, improved progression-free survival (PFS) in a phase III study. The phase III CANDOR ...

  3. Amgen Inc. AMGN announced that a three-drug combination regimen of its multiple myeloma (MM) drug Kyprolis improved progression-free survival (PFS) in a phase III study. The phase ...

  4. Top Stock Picks for Week of September 16, 2019

    Zacks via Yahoo FinanceSep 16 19:38 PM

    Amgen Inc. AMGN, discovers, develops and delivers innovative human therapeutics. Shares of this Zacks #1, Strong Buy,have risen this year so far, compared with a decline for its industry.

  5. The FDA accepts Seattle Genetics (SGEN) and Astellas' BLA for enfortumab vedotin under a priority review to treat advanced/metastatic urothelial cancer. A verdict is pending on Mar 15, 2020.

  6. REGENXBIO (RGNX) Catches Eye: Stock Jumps 5.8%

    Zacks via Yahoo FinanceSep 13 12:44 PM

    REGENXBIO Inc. RGNX was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.

  7. Top Research Reports for Amgen, Cisco & Berkshire Hathaway

    Zacks via Yahoo FinanceSep 12 17:52 PM

    Today's Research Daily features new research reports on 16 major stocks, including Amgen (AMGN), Cisco (CSCO) and Berkshire Hathaway (BRK.B). These research reports have been hand-picked ...

  8. Stocks recently featured in the blog include: Amgen AMGN, Tokyo Electron TOELY and Kinross Gold KGC. This is a Fed meeting week. With a U.S. consensus forecast for a tad above 2.0% U.S ...

  9. Puma Biotech's sNDA for Nerlynx Combo Gets FDA Acceptance

    Zacks via Yahoo FinanceSep 12 14:13 PM

    Puma Biotechnology, Inc. PBYI announced that the FDA has accepted for review its supplemental New Drug Application (sNDA) of Nerlynx (neratinib). The sNDA is seeking approval of Nerlynx ...

  10. Vertex Pharmaceuticals Incorporated VRTX announced that it has received a reimbursement approval in Scotland for its cystic fibrosis (CF) medicines Orkambi and Symkevi. Following this, approximately ...